Identification of Men With a Genetic Predisposition to Prostate Cancer: Targeted Screening in Men at Higher Genetic Risk and Controls – The Impact Study

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

EC Page, EK Bancroft, MN Brook, M Assel, M Hassan Al Battat, S Thomas, N Taylor, A Chamberlain, J Pope, HN Raghallaigh, DG Evans, J Rothwell, L Maehle, EM Grindedal, P James, L Mascarenhas, J McKinley, L Side, T Thomas, C van Asperen

2019-12-01

Background: Mutations in BRCA2 cause a higher risk of early-onset aggressive prostate cancer (PrCa). The IMPACT study is evaluatin..

Men's experiences of recontact about a potential increased risk of prostate cancer due to Lynch Syndrome: “Just another straw on the stack”

V Rasmussen, R Forbes Shepherd, LE Forrest, PA James, MA Young

2019-01-01

The practice of recontacting patients to provide new health information is becoming increasingly common in clinical genetics, desp..

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

C Mikropoulos, CGH Selkirk, S Saya, E Bancroft, E Vertosick, T Dadaev, C Brendler, E Page, A Dias, DG Evans, J Rothwell, L Maehle, K Axcrona, K Richardson, D Eccles, T Jensen, PJ Osther, CJ Van Asperen, H Vasen, LA Kiemeney

2018-01-01

Background:Prostate-specific antigen (PSA) and PSA-velocity (PSAV) have been used to identify men at risk of prostate cancer (PrCa..